title: No role for CXCL12-G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia.
authors.forename: V
authors.initials: V
authors.lastname: Ponziani
authors.forename: F
authors.initials: F
authors.lastname: Mannelli
authors.forename: N
authors.initials: N
authors.lastname: Bartalucci
authors.forename: G
authors.initials: G
authors.lastname: Gianfaldoni
authors.forename: F
authors.initials: F
authors.lastname: Leoni
authors.forename: E
authors.initials: E
authors.lastname: Antonioli
authors.forename: P
authors.initials: P
authors.lastname: Guglielmelli
authors.forename: S
authors.initials: S
authors.lastname: Ciolli
authors.forename: A
authors.initials: A
authors.lastname: Bosi
authors.forename: A M
authors.initials: AM
authors.lastname: Vannucchi
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D054377:Chemokine CXCL12 / Q000235:genetics* / Q000502:physiology; D018572:Disease-Free Survival; D005260:Female; D005838:Genotype; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000235:genetics* / Q000502:physiology; D020641:Polymorphism, Single Nucleotide; D016016:Proportional Hazards Models; D019718:Receptors, CXCR4 / Q000502:physiology; D012074:Remission Induction; D023981:Sarcoma, Myeloid / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D016019:Survival Analysis